Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

Clinical trial NCT06824987 · RECRUITING

Trial details

NCT number: NCT06824987
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

APOL1-Mediated Kidney Disease

Start date: 2025-03-05
Primary completion: 2027-08-30
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.